119 related articles for article (PubMed ID: 36089748)
41. Synthesis and antimycobacterial activity of prodrugs of indeno[2,1-c]quinoline derivatives.
Upadhayaya RS; Shinde PD; Kadam SA; Bawane AN; Sayyed AY; Kardile RA; Gitay PN; Lahore SV; Dixit SS; Földesi A; Chattopadhyaya J
Eur J Med Chem; 2011 Apr; 46(4):1306-24. PubMed ID: 21334792
[TBL] [Abstract][Full Text] [Related]
42. New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.
Vlieghe P; Bihel F; Clerc T; Pannecouque C; Witvrouw M; De Clercq E; Salles JP; Chermann JC; Kraus JL
J Med Chem; 2001 Mar; 44(5):777-86. PubMed ID: 11262088
[TBL] [Abstract][Full Text] [Related]
43. Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase.
Zhu R; Seow HA; Baumann RP; Ishiguro K; Penketh PG; Shyam K; Sartorelli AC
Bioorg Med Chem Lett; 2012 Oct; 22(19):6242-7. PubMed ID: 22932317
[TBL] [Abstract][Full Text] [Related]
44. Rapid generation of novel benzoic acid-based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study.
Li Q; Meng L; Zhou S; Deng X; Wang N; Ji Y; Peng Y; Xing J; Yao G
Eur J Med Chem; 2019 Oct; 180():509-523. PubMed ID: 31336309
[TBL] [Abstract][Full Text] [Related]
45. Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain.
Peyroche A; Antonny B; Robineau S; Acker J; Cherfils J; Jackson CL
Mol Cell; 1999 Mar; 3(3):275-85. PubMed ID: 10198630
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of acyl-CoA:cholesterol acyltransferase activity by brefeldin A in macrophage J774 cells.
Hasumi K; Naganuma S; Koshizawa J; Mogi H; Endo A
Biochim Biophys Acta; 1993 Apr; 1167(2):155-8. PubMed ID: 8466943
[TBL] [Abstract][Full Text] [Related]
47. Elucidation of strict structural requirements of brefeldin A as an inducer of differentiation and apoptosis.
Zhu JW; Nagasawa H; Nagura F; Mohamad SB; Uto Y; Ohkura K; Hori H
Bioorg Med Chem; 2000 Feb; 8(2):455-63. PubMed ID: 10722169
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and anti-HIV properties of new carbamate prodrugs of AZT.
Solyev PN; Shipitsin AV; Karpenko IL; Nosik DN; Kalnina LB; Kochetkov SN; Kukhanova MK; Jasko MV
Chem Biol Drug Des; 2012 Dec; 80(6):947-52. PubMed ID: 22958368
[TBL] [Abstract][Full Text] [Related]
49. Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailability.
Riggs JR; Kolesnikov A; Hendrix J; Young WB; Shrader WD; Vijaykumar D; Stephens R; Liu L; Pan L; Mordenti J; Green MJ; Sukbuntherng J
Bioorg Med Chem Lett; 2006 Apr; 16(8):2224-8. PubMed ID: 16458507
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
[TBL] [Abstract][Full Text] [Related]
51. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity.
Garlich JR; De P; Dey N; Su JD; Peng X; Miller A; Murali R; Lu Y; Mills GB; Kundra V; Shu HK; Peng Q; Durden DL
Cancer Res; 2008 Jan; 68(1):206-15. PubMed ID: 18172313
[TBL] [Abstract][Full Text] [Related]
52. Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy.
Devalapally H; Rajan KS; Akkinepally RR; Devarakonda RK
Drug Dev Ind Pharm; 2008 Aug; 34(8):789-95. PubMed ID: 18608462
[TBL] [Abstract][Full Text] [Related]
53. Formulating a new basis for the treatment against botulinum neurotoxin intoxication: 3,4-Diaminopyridine prodrug design and characterization.
Zakhari JS; Kinoyama I; Hixon MS; Di Mola A; Globisch D; Janda KD
Bioorg Med Chem; 2011 Nov; 19(21):6203-9. PubMed ID: 21975066
[TBL] [Abstract][Full Text] [Related]
54. Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Sata M; Moss J; Vaughan M
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2752-7. PubMed ID: 10077583
[TBL] [Abstract][Full Text] [Related]
55. Novel ProTide prodrugs of 5-fluoro-2'-deoxyuridine for the treatment of liver cancer.
Jiang L; Pan T; Lv Q; Yuan W; Liu X; Qu X; Luo D; Wan S; Cui S
Eur J Med Chem; 2023 Nov; 260():115763. PubMed ID: 37659196
[TBL] [Abstract][Full Text] [Related]
56. Synthesis, bioconversion, pharmacokinetic and pharmacodynamic evaluation of N-isopropyl-oxy-carbonyloxymethyl prodrugs of CZh-226, a potent and selective PAK4 inhibitor.
Guo J; Wang T; Wu T; Zhang K; Yin W; Zhu M; Pang Y; Hao C; He Z; Cheng M; Liu Y; Zheng J; Gu J; Zhao D
Eur J Med Chem; 2020 Jan; 186():111878. PubMed ID: 31757524
[TBL] [Abstract][Full Text] [Related]
57. Selective water-soluble gelatinase inhibitor prodrugs.
Gooyit M; Lee M; Schroeder VA; Ikejiri M; Suckow MA; Mobashery S; Chang M
J Med Chem; 2011 Oct; 54(19):6676-90. PubMed ID: 21866961
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
Chen YL; Yin Z; Lakshminarayana SB; Qing M; Schul W; Duraiswamy J; Kondreddi RR; Goh A; Xu HY; Yip A; Liu B; Weaver M; Dartois V; Keller TH; Shi PY
Antimicrob Agents Chemother; 2010 Aug; 54(8):3255-61. PubMed ID: 20516277
[TBL] [Abstract][Full Text] [Related]
59. CHNQD-00603 Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by the miR-452-3p-Mediated Autophagy Pathway.
Xin S; Li SM; Gao L; Zheng JJ; Wu YW; Shao CL; Ren WH; Zhi K
Front Cell Dev Biol; 2021; 9():779287. PubMed ID: 34993197
[No Abstract] [Full Text] [Related]
60. Synthesis and evaluation of an injectable everolimus prodrug.
Wang H; Zheng X; Cai Z; Yu O; Zheng S; Zhu T
Bioorg Med Chem Lett; 2017 Mar; 27(5):1175-1178. PubMed ID: 28169165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
